Innovation

CD244 Inhibition Useful for Memory T Cell Expansion in Chronic Infection

Emory University
posted on 01/16/2012

Application

Expansion of CD8+ Memory T Cells during chronic infection or high antigen exposure (cancer).

Key Benefits
  • Inhibition of CD244 receptor blocks memory cell loss during persistent antigen stimulation (chronic infection or cancer).
Technical Summary

By comparing the responses of memory and naive CD8+ T cells to acute and chronic lymphocytic choriomeningitis virus infection, we have shown that memory cells dominated over naive cells and were protective when present in sufficient numbers to quickly reduce infection. In contrast, when infection was not rapidly reduced, because of high antigen load or persistence, CD8+memory cells were quickly lost. This loss of memory T cells was due to a block in sustaining cell proliferation, selective regulation by the inhibitory receptor 2B4 (CD244). Thus, emphasizing the importance of designing vaccines that elicit effective T cell responses to rapidly control infection. To design successful vaccines for chronic diseases, an understanding of memory CD8+ T cell responses to persistent antigen re-stimulation is critical.

Developmental Stage
  • Proof-of-principle in vivo studies identifying role of CD244 in Memory T cell loss. (Immunity 35, 1-14, August 26, 2011.)
]]>


Innovation Details
 

File Number: 11218 


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact Cory Acuff at Emory University for more information.

Request more info via email request more info
People

Principal Investigator:

Rafi Ahmed Rafi Ahmed

Innovations (9)

Publications (7)



Co-Investigators:

Erin West Erin West

Innovations (1)

Case Manager:

Cory Acuff Cory Acuff

Innovations (75)


Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Communities
Profile
Related Tags

Find more innovations


February 11, 2009

8,771 members 16,654 innovations 159 organizations

Browse

Dr. Jörg Knäblein – Technology Scouting, Bayer Schering Pharma AG

"Through the iBridge Network, I was able to find a mouse model I was looking for. The collaboration available through the iBridge Network is crucial in driving innovation and I'll continue using it as a valued resource."  read more...